VIDEO ACCESS:

• MAYO STAFF:  Access this pre-recorded session on the Video Exchange website.  
• MAYO CLINIC CARE NETWORK:  Click here to return to the video. 

RELEASE:  June 17, 2015
EXPIRATION:  December 31, 2016 (Credit is not available after this expiration date.)

LEARNING OBJECTIVES:

• Review updates on clinical uses of enhanced cardiac ultrasound including the following:
  • Recognize the benefits, risks and safety of ultrasound enhancing agents.
  • Identify the clinical indications and applications of enhanced cardiac ultrasound.
  • Apply guideline-based ultrasound enhancing agent equipment setup and administration.
  • Assess the common pitfalls in enhanced cardiac ultrasound, and how to correct and optimize image acquisitions.
• Review the results from research applications of enhanced cardiac ultrasound in different population/disease states.

ACCREDITATION:
Mayo Clinic College of Medicine is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.  

Mayo Clinic College of Medicine designates this enduring material for a maximum of 1 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

INSTRUCTIONS:

Click the Take Course button below.
Participate in the quiz.  Participants must pass by a minimum of 80%, 1 re-take is allowed.  Quizzes have between 2-5 questions.
Complete the evaluation.  

TRANSCRIPT:
This credit will appear on your Transcript for permanent record.  To access your transcript, visit My Account, My Activities, RSS Transcript.

DISCLOSURE SUMMARY
As a provider accredited by ACCME, Mayo Clinic College of Medicine (Mayo School of CPD) must ensure balance, independence, objectivity and scientific rigor in its educational activities.  Course Director(s), Planning Committee Members, Faculty, and all others who are in a position to control the content of this educational activity are required to disclose all relevant financial relationships with any commercial interest related to the subject matter of the educational activity.  Safeguards against commercial bias have been put in place.  Faculty also will disclose any off label and/or investigational use of pharmaceuticals or instruments discussed in their presentation.  Disclosure of this information will be published in course materials so those participants in the activity may formulate their own judgments regarding the presentation.

Listed below are individuals with control of the content of this program who have disclosed…

Faculty Disclosure of Commercial Interest/Off-Label Reference

Financial relationship(s) with industry:

Planning Committee Members:
Panithaya Chareonthaitawee, M.D. – Grant/Research Support: Astellas
Thomas C. Gerber, M.D., Ph.D. – Honoraria: UpToDate (modest)

No financial relationship(s) with industry:

Merri L. Bremer, R.N., R.D.C.S.
Benjamin W. Eidem, M.D.
Garvan C. Kane, M.D., Ph.D.
Barry Karon, M.D.
Sunil V. Mankad, M.D.
Jae K. Oh, M.D.
Patricia A. Pellikka, M.D.
Sorin Pislaru, M.D., Ph.D.
Briana Rohde

Speaker:  Sharon Mulvagh, M.D., Sahar Abdelmoneim Mohamed, M.B.B.Ch.

References to off-label usage(s) of pharmaceuticals or instruments in their presentation:
None

QUESTIONS?
MAYO STAFF:   Contact Monica Schroeder
MAYO CLINIC CARE NETWORK MEMBERS:  Contact cme@mayo.edu